TY - JOUR
T1 - Development of isoform-specific sensors of polypeptide GalNAc-transferase activity
AU - Song, Lina
AU - Bachert, Collin
AU - Schjoldager, Katrine T.
AU - Clausen, Henrik
AU - Linstedt, Adam D.
N1 - Publisher Copyright:
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
PY - 2014/10/31
Y1 - 2014/10/31
N2 - Humans express up to 20 isoforms of GalNAc-transferase (herein T1-T20) that localizetothe Golgi apparatus and initiate O-glycosylation. Regulation of this enzyme family affects a vast array of proteins transiting the secretory pathway and diseases arise upon misregulation of specific isoforms. Surprisingly, molecular probes to monitor GalNAc-transferase activity are lacking and there exist no effective global or isoform-specific inhibitors. Herewedescribe the development of T2- and T3-isoform specific fluorescence sensors that traffic in the secretory pathway. Each sensor yielded little signal when glycosylated but was strongly activated in the absence of its glycosylation. Specificity of each sensor was assessed in HEK cells with either the T2 or T3 enzymes deleted. Although the sensors are based on specific substrates of the T2 and T3 enzymes, elements in or near the enzyme recognition sequence influenced their activity and required modification, which we carried out based on previous in vitrowork. Significantly, the modified T2 and T3 sensors were activated only in cells lacking their corresponding isozymes. Thus, we have developed T2- and T3-specific sensors that will be valuable in both the study of GalNAc-transferase regulation and in high-throughput screening for potential therapeutic regulators of specific GalNAc-transferases.
AB - Humans express up to 20 isoforms of GalNAc-transferase (herein T1-T20) that localizetothe Golgi apparatus and initiate O-glycosylation. Regulation of this enzyme family affects a vast array of proteins transiting the secretory pathway and diseases arise upon misregulation of specific isoforms. Surprisingly, molecular probes to monitor GalNAc-transferase activity are lacking and there exist no effective global or isoform-specific inhibitors. Herewedescribe the development of T2- and T3-isoform specific fluorescence sensors that traffic in the secretory pathway. Each sensor yielded little signal when glycosylated but was strongly activated in the absence of its glycosylation. Specificity of each sensor was assessed in HEK cells with either the T2 or T3 enzymes deleted. Although the sensors are based on specific substrates of the T2 and T3 enzymes, elements in or near the enzyme recognition sequence influenced their activity and required modification, which we carried out based on previous in vitrowork. Significantly, the modified T2 and T3 sensors were activated only in cells lacking their corresponding isozymes. Thus, we have developed T2- and T3-specific sensors that will be valuable in both the study of GalNAc-transferase regulation and in high-throughput screening for potential therapeutic regulators of specific GalNAc-transferases.
UR - http://www.scopus.com/inward/record.url?scp=84910093023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84910093023&partnerID=8YFLogxK
U2 - 10.1074/jbc.M114.599563
DO - 10.1074/jbc.M114.599563
M3 - Article
C2 - 25225288
AN - SCOPUS:84910093023
VL - 289
SP - 30556
EP - 30566
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
SN - 0021-9258
IS - 44
ER -